Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

We evaluated the safety and immunogenicity of two doses of a live-attenuated, tetravalent dengue virus vaccine (F17/Pre formulation) and a booster dose in a dengue endemic setting in two studies. Seven children (7- to 8-year-olds) were followed for 1 year after dose 2 and then given a booster dose (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Trop Med Hyg
Main Authors: Watanaveeradej, Veerachai, Simasathien, Sriluck, Mammen, Mammen P., Nisalak, Ananda, Tournay, Elodie, Kerdpanich, Phirangkul, Samakoses, Rudiwilai, Putnak, Robert J., Gibbons, Robert V., Yoon, In-Kyu, Jarman, Richard G., De La Barrera, Rafael, Moris, Philippe, Eckels, Kenneth H., Thomas, Stephen J., Innis, Bruce L.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society of Tropical Medicine and Hygiene 2016
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889756/
https://ncbi.nlm.nih.gov/pubmed/27022153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.15-0659
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares